ArticlePediatric blood & cancer2021

Phase 1 study of pomalidomide in children with recurrent, refractory, and progressive central nervous system tumors: A Pediatric Brain Tumor Consortium trial.

Jason Fangusaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.